746P Phase III MIRASOL trial: Updated overall survival results of mirvetuximab soravtansine (MIRV) vs. investigator’s choice chemotherapy (ICC) in patients (pts) with platinum-resi... von Coffman, L. Gardner, You, B., Hamilton, E.P., Garcia, Y. Garcia, Moore, K.N., Sonnenburg, D., Scambia, G., Derio, S., Pepin, J. Thomes, Klasa-Mazurkiewicz, D., Tromp, J., Breuer, S., Weroha, S., Sukhina, O., Wang, Y., Stec, J.J., Van Gorp, T.

Volltext

28. A new fibrinogen immunoprecipitation test (FIPT) predicts prevalence of cardiovascular disease in the Framingham offspring population von Stec, J.J., Silbershatz, H., Matheney, T.H., Sutherland, P., Lipinska, I., Wilson, P., Muller, J.E., D'Agostino, R.B., Tofler, G.H.

Volltext

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial von Blakemore, Stuart J., Clifford, Ruth, Parker, Helen, Antoniou, Pavlos, Stec-Dziedzic, Ewa, Larrayoz, Marta, Davis, Zadie, Kadalyayil, Latha, Colins, Andrew, Robbe, Pauline, Vavoulis, Dimitris, Forster, Jade, Carr, Louise, Morilla, Ricardo, Else, Monica, Bryant, Dean, McCarthy, Helen, Walewska, Renata J., Steele, Andrew J., Chan, Jacqueline, Speight, Graham, Stankovic, Tanja, Cragg, Mark S., Catovsky, Daniel, Oscier, David G., Rose-Zerilli, Matthew J. J., Schuh, Anna, Strefford, Jonathan C.

Volltext